Matches in Nanopublications for { ?s ?p "[In the present study, we searched for combination therapies with the dual PI3K/mTOR inhibitor NVP-BEZ235 (BEZ235) in RMS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- assertion description "[In the present study, we searched for combination therapies with the dual PI3K/mTOR inhibitor NVP-BEZ235 (BEZ235) in RMS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In the present study, we searched for combination therapies with the dual PI3K/mTOR inhibitor NVP-BEZ235 (BEZ235) in RMS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In the present study, we searched for combination therapies with the dual PI3K/mTOR inhibitor NVP-BEZ235 (BEZ235) in RMS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In the present study, we searched for combination therapies with the dual PI3K/mTOR inhibitor NVP-BEZ235 (BEZ235) in RMS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In the present study, we searched for combination therapies with the dual PI3K/mTOR inhibitor NVP-BEZ235 (BEZ235) in RMS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1259707.RAeNrml_4iJjb9f-vM6Qaq1IOlJ1G1QCjTtDUqKOirts8130_assertion description "[In the present study, we searched for combination therapies with the dual PI3K/mTOR inhibitor NVP-BEZ235 (BEZ235) in RMS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1259707.RAeNrml_4iJjb9f-vM6Qaq1IOlJ1G1QCjTtDUqKOirts8130_provenance.
- NP1259710.RACcyXpEC6f_kwh4VdiIvz6YYkGlcZWJObtQwBpOAvyqs130_assertion description "[In the present study, we searched for combination therapies with the dual PI3K/mTOR inhibitor NVP-BEZ235 (BEZ235) in RMS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1259710.RACcyXpEC6f_kwh4VdiIvz6YYkGlcZWJObtQwBpOAvyqs130_provenance.
- NP1259705.RAnkTwgtRt5EYWtDZ2woXLlwpD4Fuz1qmjVQJmf4uGBLY130_assertion description "[In the present study, we searched for combination therapies with the dual PI3K/mTOR inhibitor NVP-BEZ235 (BEZ235) in RMS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1259705.RAnkTwgtRt5EYWtDZ2woXLlwpD4Fuz1qmjVQJmf4uGBLY130_provenance.
- NP1259708.RAiJrnrElMOTlltFESKxLZGPBQccTexmzxHUy-0lMWZOY130_assertion description "[In the present study, we searched for combination therapies with the dual PI3K/mTOR inhibitor NVP-BEZ235 (BEZ235) in RMS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1259708.RAiJrnrElMOTlltFESKxLZGPBQccTexmzxHUy-0lMWZOY130_provenance.
- NP1259709.RAh9AxY-tce0Hh3kV6PemlCJ1jn8TSXdjY87MNROTwOdc130_assertion description "[In the present study, we searched for combination therapies with the dual PI3K/mTOR inhibitor NVP-BEZ235 (BEZ235) in RMS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1259709.RAh9AxY-tce0Hh3kV6PemlCJ1jn8TSXdjY87MNROTwOdc130_provenance.